Table 2.
Non-time-dependent clinical variables of the analysed intervention groups
| Variable | Group A n (%)/x ± s |
Group B n (%)/x ± s |
Group C* n (%)/x ± s |
Group D* n (%)/x ± s |
Group E n (%)/x ± s |
Group F n (%)/x ± s |
Group G n (%)/x ± s |
Group H n (%)/x ± s |
Group I n (%)/x ± s |
P-value |
|---|---|---|---|---|---|---|---|---|---|---|
| Gender female | 9 (75.0) | 5 (45.5) | 9 (42.9) | 14 (53.8) | 3 (33.3) | 12 (75.0) | 6 (60.0) | 6 (60.0) | 2 (33.3) | 0.334 |
| Age (years) | 70.4 ± 7.1 | 64.6 ± 11.0 | 61.9 ± 7.8 | 60.9 ± 9.2 | 62.7 ± 13.8 | 63.9 ± 6.2 | 61.4 ± 11.9 | 60.0 ± 8.2 | 74.8 ± 9.9 | 0.013 |
| Laterality: | ||||||||||
| Only left eye | 2 (16.7) | 0 (0) | 7 (33.3) | 11 (42.3) | 1 (11.1) | 1 (6.3) | 0 (0) | 0 (0) | 1 (16.7) | < 0.001 |
| Only right eye | 3 (25.0) | 3 (27.3) | 11 (52.4) | 8 (30.8) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Both | 7 (58.3) | 8 (72.7) | 3 (14.3) | 7 (26.9) | 8 (88.9) | 15 (93.8) | 10 (100) | 10 (100) | 5 (83.3) | |
| IOL power (D) | 20.4 ± 4.3 | 21.1 ± 2.9 | 22.1 ± 3.8 | 22.5 ± 3.8 | 20.4 ± 5.9 | 22 ± 3.2 | 21.4 ± 2.7 | 20.8 ± 3.7 | 20.8 ± 2.9 | 0.426 |
| Nd:YAG laser | 4 (21.1) | 2 (10.5) | 1 (4.2) | 1 (3) | 3 (17.6) | 2 (6.5) | 0 (0) | 0 (0) | 0 (0) | 0.068 |
| IOL substitution | 0 (0) | 6 (31.6) | 1 (4.2) | 4 (12.1) | 1 (5.9) | 0 (0) | 0 (0) | 2 (10) | 0 (0) | 0.002 |
IOL intraocular lens; Nd:YAG neodymium-doped yttrium aluminium garnet; n(%) absolute frequency (relative frequency); x ± s mean ± standard deviation
Group A: AcrySof SA60AT; Group B: SIFI Miniwell; Group C: LENTIS Mplus LS-313 MF30; Group D: LENTIS Mplus LS-313 MF15; Group E: AkkoLens Lumina; Group F: AT LISA Tri 839MP; Group G: Precizon Presbyopic; Group H: AcrySof IQ PanOptix; Group I: Tecnis Eyhance
Frequencies, means, and standard deviations were calculated for the total cases who received the intervention in the indicated eye in the specific group
*There was one patient whose left eye was included in Group C and the right eye in Group D